Global Emergency Contraceptive Pills (ECP) Market
Emergency contraception pills bestow women a last chance to avert the pregnancy after unprotected coitus. The prevalence of women with unmet contraception needs was accounted at 200 million in 2011 by WHO. The success rate of ECP is 98% for women with standard weight when taken within four days of unprotected sex The ECP is not as potent for women whose weight is more than 70kg and they are recommended copper IUD i.e. 100% effective.
Goldstein Research analyst forecast that emergency contraceptive pills market size is set to reach USD 1.25 billion by 2024, at a CAGR of 1.89% over the forecast years.
Covered In This Global Emergency Contraceptive Pills Market Report
The report covers the present ground scenario and the future growth prospects of the emergency contraceptive pills market for 2016-2024. We calculated the market size and revenue share on the basis of revenue generated from the sales of Emergency Contraceptive Pills from major players and the findings from the sales channel across the globe.
Global Emergency Contraceptive Pills Market Segmentation
By EC Pill Type
? Combination Pills
? Progesterone Pills
? Estrogen Pills
? Other Products
By Sales Channel
? Drug Stores/ Pharmacy
? Hospital Pharmacies
? Online Traders
? Other Channels
Based on Geography
? North America (U.S. & Canada) Emergency Contraceptive Pills Market
? Latin America (Brazil, Mexico, Argentina & Rest of Latin America) Emergency Contraceptive Pills Market
? Europe (The U.K., Germany, France, Italy, Spain, Poland, Sweden & RoE) Emergency Contraceptive Pills Market
? Asia-Pacific (China, India, Japan, Singapore, South Korea, Australia, New Zealand, Rest of Asia) Emergency Contraceptive Pills Market
? Middle East & Africa (GCC, South Africa, North Africa, RoMEA) Emergency Contraceptive Pills Market
On the basis of product type, Progestin-only ECPs have largely replaced the older combined ECPs because they are more effective and cause fewer side effects and hold the market share of 40% in 2016. The progesterone pills dominate the market in terms of revenue in 2016 and tend to remain the highest growing segment in the forecast years.
Emergency Contraceptive Pills Market Outlook 2016-2024, has been prepared based on an in-depth market analysis from industry experts. The report covers the competitive landscape and current position of major players in the global Emergency Contraceptive Pills market. The report also includes porters five force model, SWOT analysis, company profiling, business strategies of market players and their business models. Global market report also recognizes value chain analysis to understand the cost differentiation to provide competitive advantage to the existing and new entry players.
Our global Emergency Contraceptive Pills market report comprises of the following companies as the key players in the Emergency Contraceptive Pills market: Allergan, Lupin, Mankind, Piramal, Teva, Bayer AG.
Other high-flying vendors in the market are HLL Life Care, Pfizer, Syzygy Healthcare, V Care Pharma, HRA Pharma, Richter Gedeon Nyrt, Cooper Pharma, Zhejiang Xianju Pharmaceutical Co.
According to our global market study on the basis of extensive primary and secondary research: One of the growing trend of emergency contraceptive pills market is the advent of generic EC pills and their popularity as these pills are effective, affordable, and have no age limit. Due to their low cost, their sales and availability across drug stores have increased.
According to the report, major driver for expansion of emergency contraceptive pills market is the rising number of government initiatives directed towards curbing these unwanted abortion related expenses like family planning manoeuvre.
Further, the report states that one challenge in emergency contraceptive pills market is ineffectiveness to protect from venereal diseases and side-effects including heavy vomiting, muscle spasms, hot flashes and nauseous feeling.
Based on geography, North America holds the largest market share of 40% in 2016 while APAC is projected to witness the growth with a CAGR of 1.91% over the forecast years. Latin America and South Africa are the promising market due to the adoption of urban culture leading to increasing demand of contraceptive drugs.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
For a full detailed overview, send us the sample request.
Key questions answered in this Emergency Contraceptive Pills report
What is the total market size by 2024 and what would be the expected growth rate of the market?
What is the sale of Emergency Contraceptive Pills in 2015-16 and what would be the expected demand over the forecast period?
What are the key market trends?
What are the factors which are driving this market?
What are the major barriers to market growth?
Who are the key vendors in this market space?
What are the market opportunities for the existing and entry level players?
What are the recent developments and business strategy of the key players?
We can provide two hour complimentary interaction with our analyst after the purchase of this market report. Details are imparted within the report.